CPRX Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for people with rare debilitating diseases.

$6.95  -0.11 (-1.56%)
As of 12/03/2021 11:39:12 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/08/2006
Outstanding shares:  103,117,579
Average volume:  967,214
Market cap:   $707,386,592
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    14888U101
ISIN:        US14888U1016
Sedol:      B1G7Q03
Valuation   (See tab for details)
PE ratio:   17.50
PB ratio:   3.67
PS ratio:   5.30
Return on equity:   20.95%
Net income %:   31.16%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy